Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Frank Zavrl currently holds 8,150 shares of PUMA BIOTECHNOLOGY, INC. (PBYI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank Zavrl has been a net neutral trader of PBYI stock. They have purchased $0 and sold $0 worth of shares.
Frank Zavrl's most recent insider trade was on Jun 8, 2026, when they sold 8,150 shares at $0.00 per share.
Frank Zavrl serves as Executive at PUMA BIOTECHNOLOGY, INC. (PBYI). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Frank Zavrl holds the position of Executive at PUMA BIOTECHNOLOGY, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Frank Zavrl has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Frank Zavrl was on Jun 8, 2026, when they purchased $0 worth of CRVO shares. This transaction involved 8,150 shares at N/A per share.
Frank Zavrl currently owns 8,150 shares of PUMA BIOTECHNOLOGY, INC. (PBYI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Frank Zavrl's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Frank Zavrl has 5 Form 4 filings on record as an insider at PUMA BIOTECHNOLOGY, INC..
Set alerts for Frank Zavrl and 40,000+ other insiders.